KEGG   DRUG: Divozilimab
Entry
D12747                      Drug                                   
Name
Divozilimab (INN)
Sequence
(Heavy chain)
EVQLVQPGAE VVKPGASVKV SCKASGYTFT SYNMHWVRQA PGRGLEWMGA IYPGNGDTSY
NQKFKGRVTM TRDKSTSTVY MELSSLRSED TAVYYCARST YYGGDWYFNV WGQGTLVTVS
SASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKRVE PKSCDKTHTC PPCPAPELLG
GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY
NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTLPPSRE
EMTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSKLTVDKSR
WQQGNVFSCS VMHEALHNHY TQKSLSLSPG K
(Light chain)
QIVLSQSPAI LSASPGERVT LTCRASSSVS YIHWFQQKPG KAPKPLIYAT SNLASGVPSR
FSGSGSGTDF SLTISRVEPE DFAVYYCQQW TSNPPTFGGG TKVEIKRTVA APSVFIFPPS
DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL
SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
(Disulfide bridge: H22-H96, H148-H204, H224-L213, H230-H'230, H233-H'233, H265-H325, H371-H429, H'22-H'96, H'148-H'204, H'224-L'213, H'265-H'325, H'371-H'429, L23-L87, L133-L193, L'23-L'87, L'133-L'193)
  Type
Peptide
Remark
ATC code: L04AG15
Efficacy
Immunomodulator, Anti-CD20 antibody
  Type
Monoclonal antibody
Target
CD20 [HSA:931] [KO:K06466]
  Pathway
hsa04640  Hematopoietic cell lineage
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L04 IMMUNOSUPPRESSANTS
   L04A IMMUNOSUPPRESSANTS
    L04AG Monoclonal antibodies
     L04AG15 Divozilimab
      D12747  Divozilimab (INN)
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    CD20
     D12747  Divozilimab (INN)
Other DBs
CAS: 2254061-60-2
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system